Phospho-p38 MAPK (Thr180/Tyr182) (E3) rabbit mAb

Catalog
1156
Select Your Size Price
200 uL (0.5 mg/mL)(1156) $475.00
20 uL (0.5 mg/mL)(1156S) $175.00
$175.00
-
+

Need to make a custom order?

Contact us

Note

20 μL is enough antibody for at least 20 Western blots. 

Product Overview
Description p38 mitogen-activated protein kinase (MAPK) participates in a signaling cascade that controls cellular responses to stress signals and cytokines (1). p38 MAPK isoforms p38α, p38β, p38γ (also known as Erk6 or SAPK3), and p38δ (also known as SAPK4) have been identified. p38 MAPK activation signal include inflammatory cytokines, UV light, osmotic shock, lipopolysaccharide (LPS), and growth factors (1). MKK3, MKK6, and SEK all activate p38 MAPK by phosphorylation at Thr180 and Tyr182. phospho-p38 MAPK has been shown to phosphorylate and activate MAPKAPK-2 (2) and to phosphorylate the transcription factors ATF-2 and MEF2 (3). A selective inhibitor of phospho-p38 MAPK is SB203580 (4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-imidazole), which inhibits the MAPKAPK-2 activation by p38 MAPK and subsequent phosphorylation of HSP27 (4). SB203580 inhibits p38 MAPK catalytic activity by binding the ATP-binding pocket, but does not inhibit p38 MAPK phosphorylation by upstream kinases (5).
Product Details
More Information
Applications Flow Cytometry
Clone P38T180Y182-E3
Format Unconjugated
Cross Reactivity Predicted to work with mouse, rat and other homologues.
Detection Anti-Rabbit IgG
Formulation 1X PBS, 0.02% NaN3, 50% Glycerol, 0.1% BSA
Immunogen A synthetic phospho-peptide corresponding to residues surrounding Thr180/Tyr182 of human phospho p38 MAPK.
Isotype Rabbit IgG1k
Preparation Protein A+G
Validated Reactivity Human, Mouse, Rat
Clonality Monoclonal
Recommended Usage 1µg/mL – 0.001µg/mL. It is recommended that the reagent be titrated for optimal performance for each application. See product image legends for additional information.
References 1. Rouse, J. et al. (1994) Cell. 78:1027-1037.
2. Lee, J.C. et al. (1994) Nature. 372:739-746.
3. Raingeaud, J. et al. (1995) J. Biol. Chem. 270:7420-7426.
4. Cuenda, A. et al. (1995) FEBS Lett. 364:229-233.
5. Kumar, S. et al. (1999) Biochem. Biophys. Res. Commun. 263:825-831.
Storage -20ºC
Images
Cell Culture Products
Flow cytometric analysis of C6 cells secondary antibody only negative control (blue) or untreated (red) or treated with staurosporine (green) using phospho-p38 MAPK (Thr180/Tyr182) antibody P38T180Y182-E3 0.01 µg/mL. Cat. #1156.
Cell Culture Products
Peptide blocking flow cytometric analysis of C6 cells secondary antibody only negative control (light blue) or untreated (red) or treated with staurosporine (green) or untreated and blocked with phospho-peptide (black) or treated and blocked with phospho peptide (gold) or untreated and blocked with non-phospho peptide (dark blue) or treated and blocked with non-phospho peptide (purple) using Phospho-p38 MAPK (Thr180/Tyr182) antibody P38T180Y182-E3 at 5ng/mL. Cat. #1156.
Cell Culture Products
Flow cytometric analysis of A431 cells secondary antibody only (blue) or untreated with 0.01 µg/mL of isotype control Cat. #2141 (orange) or untreated (red) or staurosporine-treated (green) using 0.01 µg/mL of Phospho-p38 MAPK (Thr180/Tyr182) antibody P38T180Y182-E3 Cat. #1156.
Cell Culture Products
Flow cytometric analysis of C2C12 cells secondary antibody only negative control (blue) or 0.1 µg/mL of isotype control Cat. #2141 (orange) or untreated (red) or treated with staurosporine (green) using Phospho-p38 MAPK (Thr180/Tyr182) antibody P38T180Y182-E3 at 0.1 µg/mL. Cat. #1156.